Baumer S.A
Baumer S.A., together with its subsidiaries, engages in the development, industrialization, trade, production, import, export, and technical assistance of products for hospitals and industries related to the health area and for orthopedic and dental surgeries in Brazil and internationally. The company offers biomaterials for bone regeneration, including grafts and membranes; hospital equipment fo… Read more
Baumer S.A (BALM3) - Net Assets
Latest net assets as of September 2025: R$183.48 Million BRL
Based on the latest financial reports, Baumer S.A (BALM3) has net assets worth R$183.48 Million BRL as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$300.74 Million) and total liabilities (R$117.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$183.48 Million |
| % of Total Assets | 61.01% |
| Annual Growth Rate | 10.85% |
| 5-Year Change | 43.95% |
| 10-Year Change | 83.88% |
| Growth Volatility | 6.45 |
Baumer S.A - Net Assets Trend (2003–2024)
This chart illustrates how Baumer S.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Baumer S.A (2003–2024)
The table below shows the annual net assets of Baumer S.A from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | R$174.54 Million | +19.88% |
| 2023-12-31 | R$145.60 Million | +8.18% |
| 2022-12-31 | R$134.59 Million | +4.12% |
| 2021-12-31 | R$129.26 Million | +6.61% |
| 2020-12-31 | R$121.25 Million | +12.14% |
| 2019-12-31 | R$108.13 Million | +3.80% |
| 2018-12-31 | R$104.17 Million | +3.61% |
| 2017-12-31 | R$100.54 Million | +2.44% |
| 2016-12-31 | R$98.15 Million | +3.40% |
| 2015-12-31 | R$94.92 Million | +15.70% |
| 2014-12-31 | R$82.04 Million | +8.59% |
| 2013-12-31 | R$75.55 Million | +20.43% |
| 2012-12-31 | R$62.73 Million | +17.08% |
| 2011-12-31 | R$53.58 Million | +15.69% |
| 2010-12-31 | R$46.31 Million | +7.89% |
| 2009-12-31 | R$42.93 Million | +13.43% |
| 2008-12-31 | R$37.84 Million | +25.50% |
| 2007-12-31 | R$30.15 Million | +5.31% |
| 2006-12-31 | R$28.63 Million | +14.70% |
| 2005-12-31 | R$24.96 Million | +15.61% |
| 2004-12-31 | R$21.59 Million | +7.63% |
| 2003-12-31 | R$20.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Baumer S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10405200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | R$104.05 Million | 58.47% |
| Common Stock | R$70.00 Million | 39.33% |
| Other Comprehensive Income | R$3.91 Million | 2.20% |
| Total Equity | R$177.96 Million | 100.00% |
Baumer S.A Competitors by Market Cap
The table below lists competitors of Baumer S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tayih Lun An Co Ltd
TWO:8107
|
$14.88 Million |
|
Telefield Inc
KQ:091440
|
$14.88 Million |
|
FAIR ISAAC
BE:FRI
|
$14.89 Million |
|
Hofseth BioCare ASA
PINK:HOFBF
|
$14.89 Million |
|
S2 Resources Ltd
AU:S2R
|
$14.88 Million |
|
Friendly Hills Bancorp
PINK:FPBC
|
$14.87 Million |
|
Kiriacoulis Mediterranean Cruises Shipping S.A.
AT:KYRI
|
$14.87 Million |
|
Aiji net
KQ:462980
|
$14.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Baumer S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 144,240,000 to 177,960,000, a change of 33,720,000 (23.4%).
- Net income of 31,606,000 contributed positively to equity growth.
- Dividend payments of 7,484,000 reduced retained earnings.
- Other factors increased equity by 9,598,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$31.61 Million | +17.76% |
| Dividends Paid | R$7.48 Million | -4.21% |
| Other Changes | R$9.60 Million | +5.39% |
| Total Change | R$- | 23.38% |
Book Value vs Market Value Analysis
This analysis compares Baumer S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.43x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.65x to 1.43x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | R$1.91 | R$26.00 | x |
| 2004-12-31 | R$2.05 | R$26.00 | x |
| 2005-12-31 | R$1.94 | R$26.00 | x |
| 2006-12-31 | R$2.78 | R$26.00 | x |
| 2007-12-31 | R$2.97 | R$26.00 | x |
| 2008-12-31 | R$3.30 | R$26.00 | x |
| 2009-12-31 | R$3.84 | R$26.00 | x |
| 2010-12-31 | R$4.20 | R$26.00 | x |
| 2011-12-31 | R$4.82 | R$26.00 | x |
| 2012-12-31 | R$5.68 | R$26.00 | x |
| 2013-12-31 | R$7.01 | R$26.00 | x |
| 2014-12-31 | R$7.53 | R$26.00 | x |
| 2015-12-31 | R$8.79 | R$26.00 | x |
| 2016-12-31 | R$8.94 | R$26.00 | x |
| 2017-12-31 | R$9.04 | R$26.00 | x |
| 2018-12-31 | R$9.60 | R$26.00 | x |
| 2019-12-31 | R$10.27 | R$26.00 | x |
| 2020-12-31 | R$11.56 | R$26.00 | x |
| 2021-12-31 | R$13.31 | R$26.00 | x |
| 2022-12-31 | R$13.65 | R$26.00 | x |
| 2023-12-31 | R$14.74 | R$26.00 | x |
| 2024-12-31 | R$18.19 | R$26.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Baumer S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.76%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 16.26%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 1.61x
- Recent ROE (17.76%) is above the historical average (10.53%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 5.20% | 2.16% | 1.17x | 2.05x | R$-804.80K |
| 2004 | 7.06% | 2.79% | 1.13x | 2.24x | R$-530.20K |
| 2005 | 19.78% | 6.27% | 1.16x | 2.72x | R$1.67 Million |
| 2006 | 22.13% | 8.33% | 1.26x | 2.11x | R$2.97 Million |
| 2007 | 7.02% | 2.81% | 1.23x | 2.04x | R$-777.60K |
| 2008 | 13.02% | 5.69% | 1.17x | 1.95x | R$978.80K |
| 2009 | 5.27% | 2.32% | 1.10x | 2.07x | R$-1.78 Million |
| 2010 | 9.03% | 3.92% | 1.10x | 2.10x | R$-401.40K |
| 2011 | 14.69% | 7.41% | 1.06x | 1.87x | R$2.21 Million |
| 2012 | 15.19% | 8.48% | 0.99x | 1.81x | R$2.89 Million |
| 2013 | 19.12% | 12.08% | 0.87x | 1.81x | R$6.26 Million |
| 2014 | 15.58% | 9.89% | 0.85x | 1.85x | R$4.12 Million |
| 2015 | 16.66% | 12.81% | 0.69x | 1.88x | R$5.74 Million |
| 2016 | 3.44% | 2.67% | 0.66x | 1.95x | R$-5.75 Million |
| 2017 | 0.76% | 0.62% | 0.61x | 2.04x | R$-8.18 Million |
| 2018 | 2.93% | 2.30% | 0.63x | 2.02x | R$-6.65 Million |
| 2019 | 4.17% | 2.81% | 0.78x | 1.90x | R$-5.86 Million |
| 2020 | 14.53% | 5.04% | 1.52x | 1.90x | R$5.12 Million |
| 2021 | 7.78% | 3.79% | 1.17x | 1.75x | R$-2.89 Million |
| 2022 | 4.28% | 1.73% | 1.32x | 1.86x | R$-7.64 Million |
| 2023 | 6.20% | 5.26% | 0.68x | 1.73x | R$-5.48 Million |
| 2024 | 17.76% | 16.26% | 0.68x | 1.61x | R$13.81 Million |
Industry Comparison
This section compares Baumer S.A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
No peer company data available for comparison.